In addition to this clinical burden, NASH couldpotentially pose a tremendous economic burden.12 Also,NASH can negatively impact patients’ health-relatedquality of life (HRQL) and other patient-reported outcomes (PROs).13 Despite a large body of evidenceproviding information about the clinical impact of NASH,well-designed studies to assess the impact of the diseaseon PROs are scarce. Therefore, our aim was to assessPROs in patients with histologically proven NASH byusing a number of well-validated instruments